Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1223404-88-3

Post Buying Request

1223404-88-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1223404-88-3 Usage

General Description

The chemical compound "(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine" is a pyrazolo[1,5-a]pyrimidine derivative with a pyrrolidine group and difluorophenyl substituents. It is an amine compound with potential pharmaceutical applications, particularly in the field of medicinal chemistry. The compound's unique structure and functional groups make it a potentially important molecule for drug development and research into new therapeutic agents. Its specific biological and pharmacological properties would need to be further investigated and characterized for any potential pharmaceutical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1223404-88-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,3,4,0 and 4 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1223404-88:
(9*1)+(8*2)+(7*2)+(6*3)+(5*4)+(4*0)+(3*4)+(2*8)+(1*8)=113
113 % 10 = 3
So 1223404-88-3 is a valid CAS Registry Number.

1223404-88-3Downstream Products

1223404-88-3Relevant articles and documents

Assignment of NMR data and Conformational analysis of larotrectinib and its precursors

Lv, Xunlei,Zheng, Yan,Pan, Jing,Chen, Liang,Lin, Kuaile,Ye, Deyong,Zhou, Weicheng

, (2021)

NMR experiments were used to identify the two main conformations of Larotrectinib and its synthetic precursor, the nitro compound 4. Conformational analysis by dynamic NMR was performed in different temperature and solvents, combining 2D EXSY and NOE expe

Pharmaceutical compound, composition and application thereof

-

, (2020/07/15)

The invention provides a novel compound, which shows biological activity and can be used as a TRK kinase inhibitor, such as drugs for treatment of TRK-mediated diseases or symptoms and for treatment and prevention of cancers, dermatitis or asthma and the like.

Synthesis method of Larotrectinib intermediate and Larotrectinib

-

, (2019/02/27)

The invention discloses a synthesis method of Larotrectinib and a Larotrectinib intermediate. N-Boc pyrrolidone and 2,5-difluorophenyl magnesium bromide serve as raw materials, an intermediate A-1 isprepared, the intermediate A-1 is subjected to chiral catalysis hydrogenation, cyclization or first cyclization and afterwards chiral catalysis hydrogenation to obtain a chiral pyrrodlidine intermediate A-4, the intermediate A-4 and an intermediate B-3 are condensed to obtain an intermediate AB-1, the intermediate AB-1 is reduced to obtain an intermediate AB-2, the AB-2 is acylated to obtain an intermediate AB-3, and the AB-3 is subjected to a substitution reaction to obtain the target product Larotrectinib (AB-4). The intermediate A-4 with a high yield and high chiral purity is obtained through a chiral catalysis method, the B-3 with a high yield is obtained through a solvent-free one-pot method, and the Larotrectinib (AB-4) with a high yield and high purity is obtained. According to themethod, the reaction condition can also be applied to large-scale preparation, the method is suitable for industrial production, and therefore, the method has high practical values and social and economic benefits.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1223404-88-3